APO RESEARCH · REPORT
Liquid Biopsy Products
Liquid biopsies are a sequencing-based technology used to screen blood for tiny fragments of genetic material released by cancer tissue, known as circulating tumor (ct) DNA.
Product & engineering
Understand the product.
Liquid biopsies are a sequencing-based technology used to screen blood for tiny fragments of genetic material released by cancer tissue, known as circulating tumor (ct) DNA.
This report mainly covers the Liquid Biopsy Products product type by technology (circulating Tumor Cells (CTCs), circulating tumor DNA (ctDNA), and extracellular vesicles (or exosomes)), by sample type (blood, urine and other bio fluids (Tissue fluids and Saliva based)), while we can also offer any product survey report related to the liquid biopsy products industry chain.
Selected research
Industry Growth & Trends
Global Liquid Biopsy Products Industry Growth and Trends Forecast to 2032
Market perspective
Liquid biopsies are a sequencing-based technology used to screen blood for tiny fragments of genetic material released by cancer tissue, known as circulating tumor (ct) DNA.
This report mainly covers the Liquid Biopsy Products product type by technology (circulating Tumor Cells (CTCs), circulating tumor DNA (ctDNA), and extracellular vesicles (or exosomes)), by sample type (blood, urine and other bio fluids (Tissue fluids and Saliva based)), while we can also offer any product survey report related to the liquid biopsy products industry chain.
According to APO Research, the global Liquid Biopsy Products market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
Read the full market overview
Report Scope
This report provides a structured, data-driven view of the global Liquid Biopsy Products market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Liquid Biopsy Products market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Liquid Biopsy Products market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Liquid Biopsy Products.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Liquid Biopsy Products market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Liquid Biopsy Products Market by Company
RainDanceTechnologies
Biocartis
Qiagen
Guardant Health
MDxHealth
Pathway Genomics
NeoGenomics Laboraories
Sysmex Inostics
Cynvenio
Menarini Silicon Biosystems
Adaptive Biotechnologies
Biocept
Angle plc
Liquid Biopsy Products Segment by Type
CTCs
ctDNA
Exosomes
Liquid Biopsy Products Segment by Application
Blood Sample
Urine Sample
Other Bio Fluids
Liquid Biopsy Products Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liquid Biopsy Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Liquid Biopsy Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liquid Biopsy Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Liquid Biopsy Products companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- CTCs
- ctDNA
- Exosomes
Applications
- Blood Sample
- Urine Sample
- Other Bio Fluids
Companies covered
- RainDanceTechnologies
- Biocartis
- Qiagen
- Guardant Health
- MDxHealth
- Pathway Genomics
- NeoGenomics Laboraories
- Sysmex Inostics
- Cynvenio
- Menarini Silicon Biosystems
- Adaptive Biotechnologies
- Biocept
- Angle plc
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Liquid Biopsy Products Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Liquid Biopsy Products Market Size by Region (2021-2032)
- 1.4.1 Global Liquid Biopsy Products Market Size by Region (2021-2026)
- 1.4.2 Global Liquid Biopsy Products Market Size by Region (2027-2032)
- 1.5 Key Regions Liquid Biopsy Products Market Size (2021-2032)
- 1.5.1 North America Liquid Biopsy Products Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Liquid Biopsy Products Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Liquid Biopsy Products Market Size Growth Rate (2021-2032)
- 1.5.4 South America Liquid Biopsy Products Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Liquid Biopsy Products Market Size Growth Rate (2021-2032)
2 Liquid Biopsy Products Market by Type
- 2.1 Type Introduction
- 2.1.1 CTCs
- 2.1.2 ctDNA
- 2.1.3 Exosomes
- 2.2 Global Liquid Biopsy Products Market Size by Type
- 2.2.1 Global Liquid Biopsy Products Market Size Overview by Type (2021-2032)
- 2.2.2 Global Liquid Biopsy Products Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Liquid Biopsy Products Market Size Forecasted by Type (2027-2032)
- 2.3 Global Liquid Biopsy Products Market Size by Regions
- 2.3.1 North America Liquid Biopsy Products Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Liquid Biopsy Products Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Liquid Biopsy Products Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Liquid Biopsy Products Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Liquid Biopsy Products Market Size Breakdown by Type (2021-2026)
3 Liquid Biopsy Products Market by Application
- 3.1 Type Introduction
- 3.1.1 Blood Sample
- 3.1.2 Urine Sample
- 3.1.3 Other Bio Fluids
- 3.2 Global Liquid Biopsy Products Market Size by Application
- 3.2.1 Global Liquid Biopsy Products Market Size Overview by Application (2021-2032)
- 3.2.2 Global Liquid Biopsy Products Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Liquid Biopsy Products Market Size Forecasted by Application (2027-2032)
- 3.3 Global Liquid Biopsy Products Market Size by Regions
- 3.3.1 North America Liquid Biopsy Products Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Liquid Biopsy Products Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Liquid Biopsy Products Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Liquid Biopsy Products Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Liquid Biopsy Products Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Liquid Biopsy Products Industry Trends
- 4.2 Liquid Biopsy Products Industry Drivers
- 4.3 Liquid Biopsy Products Industry Opportunities and Challenges
- 4.4 Liquid Biopsy Products Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Liquid Biopsy Products Revenue (2021-2026)
- 5.2 Global Liquid Biopsy Products Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Liquid Biopsy Products Key Company Headquarters & Area Served
- 5.4 Global Liquid Biopsy Products Company, Product Type & Application
- 5.5 Global Liquid Biopsy Products Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Liquid Biopsy Products Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Liquid Biopsy Products Players Market Share by Revenue in 2025
- 5.6.3 2025 Liquid Biopsy Products Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 RainDanceTechnologies
- 6.1.1 RainDanceTechnologies Company Information
- 6.1.2 RainDanceTechnologies Business Overview
- 6.1.3 RainDanceTechnologies Liquid Biopsy Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 RainDanceTechnologies Liquid Biopsy Products Product Portfolio
- 6.1.5 RainDanceTechnologies Recent Developments
- 6.2 Biocartis
- 6.2.1 Biocartis Company Information
- 6.2.2 Biocartis Business Overview
- 6.2.3 Biocartis Liquid Biopsy Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Biocartis Liquid Biopsy Products Product Portfolio
- 6.2.5 Biocartis Recent Developments
- 6.3 Qiagen
- 6.3.1 Qiagen Company Information
- 6.3.2 Qiagen Business Overview
- 6.3.3 Qiagen Liquid Biopsy Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Qiagen Liquid Biopsy Products Product Portfolio
- 6.3.5 Qiagen Recent Developments
- 6.4 Guardant Health
- 6.4.1 Guardant Health Company Information
- 6.4.2 Guardant Health Business Overview
- 6.4.3 Guardant Health Liquid Biopsy Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Guardant Health Liquid Biopsy Products Product Portfolio
- 6.4.5 Guardant Health Recent Developments
- 6.5 MDxHealth
- 6.5.1 MDxHealth Company Information
- 6.5.2 MDxHealth Business Overview
- 6.5.3 MDxHealth Liquid Biopsy Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 MDxHealth Liquid Biopsy Products Product Portfolio
- 6.5.5 MDxHealth Recent Developments
- 6.6 Pathway Genomics
- 6.6.1 Pathway Genomics Company Information
- 6.6.2 Pathway Genomics Business Overview
- 6.6.3 Pathway Genomics Liquid Biopsy Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Pathway Genomics Liquid Biopsy Products Product Portfolio
- 6.6.5 Pathway Genomics Recent Developments
- 6.7 NeoGenomics Laboraories
- 6.7.1 NeoGenomics Laboraories Company Information
- 6.7.2 NeoGenomics Laboraories Business Overview
- 6.7.3 NeoGenomics Laboraories Liquid Biopsy Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 NeoGenomics Laboraories Liquid Biopsy Products Product Portfolio
- 6.7.5 NeoGenomics Laboraories Recent Developments
- 6.8 Sysmex Inostics
- 6.8.1 Sysmex Inostics Company Information
- 6.8.2 Sysmex Inostics Business Overview
- 6.8.3 Sysmex Inostics Liquid Biopsy Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Sysmex Inostics Liquid Biopsy Products Product Portfolio
- 6.8.5 Sysmex Inostics Recent Developments
- 6.9 Cynvenio
- 6.9.1 Cynvenio Company Information
- 6.9.2 Cynvenio Business Overview
- 6.9.3 Cynvenio Liquid Biopsy Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Cynvenio Liquid Biopsy Products Product Portfolio
- 6.9.5 Cynvenio Recent Developments
- 6.10 Menarini Silicon Biosystems
- 6.10.1 Menarini Silicon Biosystems Company Information
- 6.10.2 Menarini Silicon Biosystems Business Overview
- 6.10.3 Menarini Silicon Biosystems Liquid Biopsy Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Menarini Silicon Biosystems Liquid Biopsy Products Product Portfolio
- 6.10.5 Menarini Silicon Biosystems Recent Developments
- 6.11 Adaptive Biotechnologies
- 6.11.1 Adaptive Biotechnologies Company Information
- 6.11.2 Adaptive Biotechnologies Business Overview
- 6.11.3 Adaptive Biotechnologies Liquid Biopsy Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Adaptive Biotechnologies Liquid Biopsy Products Product Portfolio
- 6.11.5 Adaptive Biotechnologies Recent Developments
- 6.12 Biocept
- 6.12.1 Biocept Company Information
- 6.12.2 Biocept Business Overview
- 6.12.3 Biocept Liquid Biopsy Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Biocept Liquid Biopsy Products Product Portfolio
- 6.12.5 Biocept Recent Developments
- 6.13 Angle plc
- 6.13.1 Angle plc Company Information
- 6.13.2 Angle plc Business Overview
- 6.13.3 Angle plc Liquid Biopsy Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Angle plc Liquid Biopsy Products Product Portfolio
- 6.13.5 Angle plc Recent Developments
7 North America
- 7.1 North America Liquid Biopsy Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Liquid Biopsy Products Market Size by Country (2021-2026)
- 7.3 North America Liquid Biopsy Products Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Liquid Biopsy Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Liquid Biopsy Products Market Size by Country (2021-2026)
- 8.3 Europe Liquid Biopsy Products Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Liquid Biopsy Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Liquid Biopsy Products Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Liquid Biopsy Products Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Liquid Biopsy Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Liquid Biopsy Products Market Size by Country (2021-2026)
- 10.3 South America Liquid Biopsy Products Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Liquid Biopsy Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Liquid Biopsy Products Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Liquid Biopsy Products Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst